About this item:
381 Views | 622 Downloads
Author Notes:
Corresponding author at: 720 Westview Drive SW, Atlanta, GA 30310, USA
Authors would like to thank Natalia Kozyk, PhD, for her work on microarray testing, Frederick Bright, MD, for the intraoperative photograph and the medical oncology team under Myra Rose, MD for chemotherapy care of the patient.
The authors have no conflicts of interest to declare.
Subjects:
Keywords:
- Chemotherapy
- Human chorionic gonadotropin
Endometrial carcinoma with ectopic human chorionic gonadotropin expression
Abstract:
Aggressive course and treatment resistance characterize ectopic human chorionic gonadotropin.
Recurrence of endometrial cancer with ectopic hCG was treated with brachytherapy and EMACO.
The serum hCG level can serve as a marker in tumors with ectopic hCG expression.
Copyright information:
© 2015 The Authors
This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).
